KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Net Margin (2016 - 2025)

Historic Net Margin for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to 296.76%.

  • Nektar Therapeutics' Net Margin fell 1431500.0% to 296.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 181.12%, marking a year-over-year decrease of 4200.0%. This contributed to the annual value of 120.89% for FY2024, which is 1854200.0% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Net Margin of 296.76% as of Q3 2025, which was down 1431500.0% from 350.85% recorded in Q2 2025.
  • Nektar Therapeutics' Net Margin's 5-year high stood at 24.8% during Q4 2024, with a 5-year trough of 736.94% in Q2 2022.
  • Its 5-year average for Net Margin is 346.71%, with a median of 302.43% in 2022.
  • Per our database at Business Quant, Nektar Therapeutics' Net Margin tumbled by -2938800bps in 2022 and then surged by 4875500bps in 2023.
  • Quarter analysis of 5 years shows Nektar Therapeutics' Net Margin stood at 587.42% in 2021, then surged by 49bps to 302.43% in 2022, then soared by 42bps to 176.17% in 2023, then soared by 114bps to 24.8% in 2024, then plummeted by -1297bps to 296.76% in 2025.
  • Its last three reported values are 296.76% in Q3 2025, 350.85% for Q2 2025, and 443.8% during Q1 2025.